BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14659323)

  • 1. Immunohistochemical evaluation of immune response in invasive ductal breast cancer of not-otherwise-specified type.
    Vgenopoulou S; Lazaris AC; Markopoulos C; Boltetsou E; Kyriakou V; Kavantzas N; Patsouris E; Davaris PS
    Breast; 2003 Jun; 12(3):172-8. PubMed ID: 14659323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues.
    Pereira MB; Dias AJ; Reis CA; Schmitt FC
    J Clin Pathol; 2001 Mar; 54(3):210-3. PubMed ID: 11253133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors.
    Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K
    Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast.
    Diaz LK; Wiley EL; Morrow M
    Breast J; 2001; 7(1):40-5. PubMed ID: 11348414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.
    Mohammed ZM; Going JJ; Edwards J; Elsberger B; McMillan DC
    Br J Cancer; 2013 Sep; 109(6):1676-84. PubMed ID: 23982600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.
    Ohashi R; Hayama A; Yanagihara K; Yamashita K; Sakatani T; Takei H; Naito Z
    Diagn Pathol; 2016 Nov; 11(1):131. PubMed ID: 27846863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
    Helal TE; Ibrahim EA; Alloub AI
    Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary study on lymphocyte subsets of sentinel lymph nodes in breast cancer patients].
    Wang S; Fan P; Wu ZY
    Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):220-2. PubMed ID: 15312384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
    Yonezawa S; Sato E
    Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas.
    Do SI; Kim K; Kim DH; Chae SW; Park YL; Park CH; Sohn JH
    J Breast Cancer; 2013 Jun; 16(2):152-8. PubMed ID: 23843846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis.
    Schmitt FC; Figueiredo P; Lacerda M
    Virchows Arch; 1995; 427(3):251-8. PubMed ID: 7496593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas.
    Pupa SM; Bufalino R; Invernizzi AM; Andreola S; Rilke F; Lombardi L; Colnaghi MI; Ménard S
    J Clin Oncol; 1996 Jan; 14(1):85-94. PubMed ID: 8558226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas.
    Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the tumor infiltrating natural killer cell (NK-TILs) count in infiltrating ductal carcinoma of breast prognostically significant?
    Rathore AS; Goel MM; Makker A; Kumar S; Srivastava AN
    Asian Pac J Cancer Prev; 2014; 15(8):3757-61. PubMed ID: 24870789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses.
    Wang EC; Taylor-Wiedeman J; Perera P; Fisher J; Borysiewicz LK
    Clin Exp Immunol; 1993 Nov; 94(2):297-305. PubMed ID: 7693383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association with clinicopathological prognostic factors.
    Jafarian AH; Tasbandi A; Gilan H; Sheikhi M; Roshan NM
    Indian J Pathol Microbiol; 2018; 61(4):500-504. PubMed ID: 30303137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.
    McNerlan SE; Rea IM; Alexander HD; Morris TC
    J Clin Immunol; 1998 Jan; 18(1):31-8. PubMed ID: 9475351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.